Hadassah

Conquering Brain Tumors at the Molecular Level

Monday, Dec 9 2013

For Regina Golan-Gerstl, a postdoctoral fellow at the Hadassah-Hebrew University School of Medicine, the fight against brain cancer has been close-up and personal: her mother died of the disease. She has now identified a genetic protein that is directly implicated in the development of the most prevalent brain cancer--glioblastoma.

Initially working in the specialty of pulmonology with Senior Hadassah Prof. Raphael Breuer, researching how cells communicate with one another, Dr. Golan-Gerstl switched to studying brain cancer when her mother became ill.

There is a mechanism called "splicing," she says, where elements of RNA (ribonucleic acid) are cut and recombined like sections of movie film. When a person is sick, Dr. Golan-Gerstl explains, the splicing mechanism doesn't work in the same way. An alternative splicing occurs, thanks to a genetic protein which becomes an activist in the development of cancer. She and her team have found that when the action of this gene is turned off, tumors in mice decrease in size. Dr. Golan-Gerstl adds that their first success has been with brain cancer.

Further investigation is taking place with other metastatic cancers, such as breast cancer. Tackling the problem with colleagues in Hadassah's Neuro-Oncology Department, Dr. Golan-Gerstl relates that they are "working on shutting it down at a molecular level."

Michael Klipper, Chair of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on the organization's website that "this discovery is comforting for those who are and who have been affected by this horrible disease. For one, it shows them that there are dedicated scientists and researchers who are working around the clock to put an end to this horrible disease. And two, it gives them hope that there actually will one day be a cure for brain cancer."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Mar 22 2019

On World TB Day, March 24, Hadassah Celebrates Its Success Treating TB

Hadassah has been working on reducing the incidence of tuberculosis for nearly 100 years.

READ MORE ›
alt_text

Thursday, Mar 21 2019

Large Multinational Study Reveals Benefits of Dapagliflozin for Treatment of Diabetes

With 450 million adults worldwide suffering from diabetes today and an increase to more than 640 million expected by 2040, the need for a safe and effective treatment is ever more compelling.

READ MORE ›
alt_text

Tuesday, Mar 19 2019

Hadassah Genetic Research Demystifies Causes of Day Blindness in Families

Fifteen years ago, Prof. Dror Sharon joined the Hadassah Medical Organization’s Center for Retinal and Macular Degeneration to study the genetics of eye disease.

READ MORE ›
alt_text

Wednesday, Mar 13 2019

Saving Lives, Changing Lives at Hadassah-Neurim Youth Aliyah Village

Henrietta Szold was the mother of Youth Aliyah. The first young Jews who came on their own in the mid-1930s were fleeing Hitler. Many never saw their parents again, and they called her Ima. She met their boats, welcomed them, and became their staunch advocate in the no-frills pre-state Israel.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More